A new malaria antibody treatment may keep more people free of the sometimes deadly disease for up to six months in regions where infection rates are high. Instead of requiring the immune system to make enough antibodies, this experimental drug provides those who receive it with a large amount of lab-made antibodies. It requires an… read on > read on >



















